Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT06369285 |
Title | A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer (ALISCA-Breast1) |
Acronym | ALISCA-Breast1 |
Recruitment | Recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Puma Biotechnology, Inc. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Alabama Oncology | RECRUITING | Birmingham | Alabama | 34235 | United States | Details |
Mayo Clinic Hospital | RECRUITING | Phoenix | Arizona | 85054 | United States | Details |
LA Cancer Network | RECRUITING | Los Angeles | California | 90017 | United States | Details |
University of California San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center | RECRUITING | San Francisco | California | 94158 | United States | Details |
Yale University, Yale Cancer Center | RECRUITING | New Haven | Connecticut | 06520 | United States | Details |
Mayo Clinic Florida | RECRUITING | Jacksonville | Florida | 32224 | United States | Details |
Mayo Clinic | RECRUITING | Rochester | Minnesota | 55905 | United States | Details |
Taylor Cancer Research Center | RECRUITING | Maumee | Ohio | 43537 | United States | Details |